Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. (not Streamex Corp.) on April 15, 2021. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The report primarily addresses a Regulation FD disclosure regarding personnel changes.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
The material change disclosed is the appointment of two new Regional Directors with experience in electrophysiology. These executives will lead commercial expansion efforts in the Southeast and Central regions of the United States.
Guidance, Outlook, and Risks
The Company explicitly states it undertakes no obligation to update, supplement, or amend the materials attached to this report. The filing includes standard disclaimers that the information is not deemed "filed" for liability purposes under Section 18 of the Exchange Act and is not intended to constitute a determination of materiality under Regulation FD.
Investor Verification Checklist
- Verify the correct registrant name is BioSig Technologies, Inc. (BSGM), not Streamex Corp.
- Confirm the specific qualifications and backgrounds of the two newly appointed Regional Directors.
- Review the attached Exhibit 99.1 (Press Release) for further details on the commercial expansion strategy.
- Note that no financial data or forward-looking guidance is included in this specific filing.